HPV infection and p16 promoter methylation as predictors of ASC-US/LSIL progression.

about

Associations of P16INK4a promoter hypermethylation with squamous intra-epithelial lesion, cervical cancer and their clinicopathological features: a meta-analysis Role of p16 testing in cervical cancer screening among HIV-infected women

P2860

Q28078542-A71DFFD3-40C3-43A6-AF47-5C3DCDFAB7A5 Q41986617-C93E636D-E84F-4251-9D64-FDCA7C8C53F2

P2860

HPV infection and p16 promoter methylation as predictors of ASC-US/LSIL progression.

Item

http://www.wikidata.org/entity/Q40578877

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

HPV infection and p16 promoter methylation as predictors of ASC-US/LSIL progression.

@en

type

Item

label

HPV infection and p16 promoter methylation as predictors of ASC-US/LSIL progression.

@en

prefLabel

HPV infection and p16 promoter methylation as predictors of ASC-US/LSIL progression.

@en

P1476

HPV infection and p16 promoter methylation as predictors of ASC-US/LSIL progression.

@en

P2093

Eun-Ju Lee

http://www.w3.org/2001/XMLSchema#string

Hee Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype.

The 2001 Bethesda System: terminology for reporting results of cervical cytology.

The Prognostic Value of p16 Hypermethylation in Cancer: A Meta-Analysis.

Smoking initiation is followed by the early acquisition of epigenetic change in cervical epithelium: a longitudinal study.

Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis.

Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions

In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis.

A cervical abnormality risk prediction model: can we use clinical information to predict which patients with ASCUS/LSIL Pap tests will develop CIN 2/3 or AIS?

Epstein-Barr virus and p16INK4A methylation in squamous cell carcinoma and precancerous lesions of the cervix uteri.

HPV DNA testing improves CIN2+ risk stratification and detection of CIN2+ in delayed triage of ASCUS and LSIL. A population-based follow-up study from Western Norway.

P304

58-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCY.21615

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26335500

http://www.w3.org/2001/XMLSchema#string

HPV infection and p16 promoter methylation as predictors of ASC-US/LSIL progression.

about

P2860

P2860

HPV infection and p16 promoter methylation as predictors of ASC-US/LSIL progression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698